Systematic review with network meta‐analysis: comparative efficacy of pharmacologic therapies for fibrosis improvement and resolution of NASH-Reference-Cited by-同舟云学术

Systematic review with network meta‐analysis: comparative efficacy of pharmacologic therapies for fibrosis improvement and resolution of NASH

Published:2021-08-25 Issue:7 Volume:54 Page:880-889
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Majzoub Abdul M.¹,Nayfeh Tarek²,Barnard Abbey³,Munaganuru Nagambika³,Dave Shravan³^ORCID,Singh Siddharth³,Murad Mohammad Hassan²,Loomba Rohit³^ORCID

Affiliation:

1. Division of Internal Medicine Conemaugh Memorial Medical Center Johnstown Pennsylvania USA

2. Evidence‐Based Practice Center Mayo Clinic Rochester Minnesota USA

3. NAFLD Research Center Division of Gastroenterology and Hepatology Department of Medicine University of California at San Diego San Diego California USA

Funder

National Institute of Environmental Health Sciences

National Center for Advancing Translational Sciences

National Institute of Diabetes and Digestive and Kidney Diseases

National Heart, Lung, and Blood Institute

National Institute on Alcohol Abuse and Alcoholism

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.16583

Reference50 articles.

1. Nonalcoholic Steatohepatitis Is the Most Rapidly Increasing Indication for Liver Transplantation in the United States

2. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease

3. Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis

4. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

5. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging Combination of Saroglitazar and Vitamin E for the Treatment of NAFLD and NASH;Journal of Clinical and Experimental Hepatology;2024-09

2. Comparative efficacy of pharmacologic therapies for MASH in reducing liver fat content: Systematic review and network meta-analysis;Hepatology;2024-07-19

3. The effect of vitamin E and docosahexaenoic acid ethyl ester on Metabolic Dysfunction‐Associated steatotic Liver Disease (MASLD)—A randomised, double‐blind, placebo‐controlled, parallel‐group clinical trial (PUVENAFLD);Alimentary Pharmacology & Therapeutics;2024-07-12

4. Efficacy and safety of aldafermin in non-alcoholic steatohepatitis: A systematic review and meta-analysis of randomized controlled trials;Clinics and Research in Hepatology and Gastroenterology;2024-06

5. New and emerging treatments for metabolic dysfunction-associated steatohepatitis;Cell Metabolism;2024-05